Table 1. Subjects used in the genome-wide association meta-analysis of IgM anti-PC.
Discovery phase | Replication | ||||
---|---|---|---|---|---|
TwinGene | PIVUS | MDC | PRACSIS | ||
Numbers | |||||
All | 1175 | 945 | 882 | 646 | |
Male | 629 | 473 | 494 | 461 | |
Female | 546 | 472 | 388 | 185 | |
Age (years) | |||||
All | 74.2 ± 5.6 | 70.2 ± 0.2 | 60.8 ± 5.0 | 64.5 ± 9.5 | |
Male | 73.9 ± 5.4 | 70.1 ± 0.1 | 60.7 ± 4.9 | 63.7 ± 9.6 | |
Female | 74.5 ± 5.7 | 70.2 ± 0.2 | 60.9 ± 5.2 | 66.4 ± 8.9 | |
IgM anti-PC (U/ml) | |||||
All | 42.7 (23.3−72.9) | 42.4 (27.0−73.4) | 48.0 (29.9−75.8) | 34.9 (21.2−60.4) | |
Male | 42.6 (22.7−69.8) | 39.1 (24.5−65.3) | 48.0 (28.9−78.2) | 35.1 (22.2−58.7) | |
Female | 42.8 (24.1−74.3) | 47.9 (29.7−79.9) | 48.0 (21.9−74.4) | 34.0 (20.3−67.4) |
Distribution of age is described as mean±SD; the raw values of IgM anti-PC are skewed distributed and presented by median (interquartile range, the 25th percentile– the 75th percentile).